This compound is an active pharmaceutical ingredient (API) characterized by a complex heterocyclic structure containing multiple aromatic rings, ether groups, and a urea moiety. Its primary significance lies in its use as a pharmaceutical raw material for research and manufacturing.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Ensifentrine (stereochemically undefined)
pharmaceutical raw material
9,10-Dimethoxy-2-(2,4,6-trimethylphenylimino)3-(2-aminoethyl)-3,4,6,7-tetrahydro-2H-pyrimido[6,1-a]isoquinolin-4-one
pharmaceutical raw material
Eptifibatide
pharmaceutical raw material
(2S)-Hydroxy(phenyl)acetic acid (2R)-N-benzyl-1-(4-methoxyphenyl)propan-2-amine
pharmaceutical raw material
D-Glucose, 2-deoxy-2-[[(methylnitrosoamino)carbonyl]amino]-
pharmaceutical raw material
4-(2-(tert-butylamino)-1-hydroxyethyl)-2-methylphenol
pharmaceutical raw material
2-(mesitylamino)-9,10-dimethoxy-6,7-dihydro-4H-pyrimido[6,1-a]isoquinolin-4-one
research compound
The international HS code for N-[2-[6,7-Dihydro-9,10-dimethoxy-4-oxo-2-[(2,4,6-trimethylphenyl)imino]-2H-pyrimido[6,1-a]isoquinolin-3(4H)-yl]ethyl]urea (CAS 1884461-72-6) is 2933.59.
2933.59
2933 59 95
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
2-[9,10-dimethoxy-4-oxo-2-(2,4,6-trimethylphenyl)imino-6,7-dihydropyrimido[6,1-a]isoquinolin-3-yl]ethylurea
CSOBIBXVIYAXFM-UHFFFAOYSA-N
CC1=CC(=C(C(=C1)C)N=C2C=C3C4=CC(=C(C=C4CCN3C(=O)N2CCNC(=O)N)OC)OC)C
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.